MEDENT Adopts Surescripts' Direct Messaging for Enhanced

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MEDENT Adopts Surescripts' Direct Messaging for Enhanced Clinical Interoperability

ARLINGTON, VA--(Marketwired - Jun 5, 2013) - MEDENT, a recognized leader in the healthcare practice management automation market, has added Surescripts' Basic Messaging and Communications product to its suite of services available to more than 7,000 healthcare providers currently using MEDENT's Meaningful Use-certified, all-in-one electronic health record (EHR), patient portal and practice management system. Surescripts Basic Messaging and Communications is a subscription service that allows patient-specific protected health information to be instantaneously and securely transmitted between healthcare providers, leading to increased efficiency, informed care decisions, better patient outcomes, and lower healthcare costs.

MEDENT EHR physician practices using Surescripts Basic Messaging and Communications will enhance care coordination within and across healthcare provider organizations by enabling instant, streamlined communication and secure messaging among care teams. MEDENT's EHR system is used by provider organizations in nine states across New England, the Mid-Atlantic and Midwest, including Trinity Family Medicine, in Weedsport, NY. As an early adopter of Surescripts Basic Messaging and Communications integrated with MEDENT's EHR system, Trinity Family Medicine leveraged this new clinical interoperability capability and saw immediate benefits (see also: http://www.medent.com/CaseStudys/trinity.pdf ). 

"For the first time, it's possible to securely interact with another physician without being on the phone and taking time away from the patient," said Dr. Sean Boyle, M.D., physician and founder of Trinity Family Practice. "In two minutes, without having to think about it, I can take the referral from one level to the next," Dr. Boyle added. "In the past, the process would have taken 15 to 20 minutes of my time."

"Clinical interoperability is playing an increasingly critical role in addressing national care and compliance mandates, such as supporting the meaningful use of EHRs and accountable care organizations," said Gary Cuthbert, president, MEDENT. "By leveraging Surescripts Basic Messaging and Communications capabilities, our healthcare providers are able to more efficiently interact with one another and receive information on common patients, as well as transmit information through federally-approved communication platforms. The result is enhanced care coordination and collaboration among the healthcare providers we serve."

Surescripts' portfolio of clinical interoperability solutions allow clinical care information -- including clinical messages, immunization summaries, CCDs, referrals, discharge summaries and lab results -- to be transmitted between doctors, practices and health systems locally and nationally across all technology platforms. 

"As the healthcare landscape rapidly transforms with Meaningful Use Stage 2 requirements and other care management imperatives, the need for clinical interoperability grows exponentially," said Jeff Miller, senior vice president and general manager, Clinical Interoperability, Surescripts. "MEDENT's addition of Basic Messaging and Communications substantially increases our network reach in the Northeast and helps us continue to improve connectivity and collaboration at the community level where healthcare happens."

Surescripts Basic Messaging and Communications is based on Direct messaging protocols launched in 2010 by the Office of the National Coordinator for Health Information Technology (ONC) as part of the Direct Project to specify a simple, secure, scalable, standards-based way for participants to send authenticated, encrypted health information directly to known, trusted recipients over the Internet. Surescripts recently received full accreditation from the Direct Trusted Agent Accreditation Program (DTAAP), an accreditation program for health information service providers (HISPs). DTAAP is offered on a voluntary basis by DirectTrust, an independent non-profit association dedicated to securing the exchange of health information between providers and patients.

MEDENT joins Epic, GE, NextGen, NewCrop and several other EHR technology vendors that have connected to the Surescripts network. Surescripts' clinical interoperability capabilities have the ability to connect to an eligible universe of 300,000 care providers in acute (hospital) and ambulatory (office practices) settings across the United States. The network supports all federal and state policies and standards for health information exchange, including privacy and security standards, technology interoperability standards, and message types.

About Surescripts The Surescripts network supports the most comprehensive ecosystem of healthcare organizations nationwide. Pharmacies, payers, pharmacy benefit managers, physicians, hospitals, health information exchanges and health technology firms rely on Surescripts to more easily and securely share health information. Guided by the principles of neutrality, transparency, physician and patient choice, open standards, collaboration and privacy, Surescripts operates the nation's largest health information network. By providing information for routine, recurring and emergency care, Surescripts is committed to saving lives, improving efficiency and reducing the cost of health care for all. For more information, go to www.surescripts.com and follow us at twitter.com/surescripts .

Media Contact: Kelly Newton Surescripts 571-384-4776 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 171

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 140

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
WhiteHorse Set to Redeem Its 2028 Notes Completely

Updated Category News Views 104

WhiteHorse Finance Divests Its 7.875% Notes Well, WhiteHorse Finance is making some moves, folks. They're planning to redeem their 7.875% notes due in 2028, totaling a cool $34.5 million. This ain't just pocket change, especially with the way markets have been bobbing and weaving lately. The redemption is slated for December 15, 2026, when the notes will get delisted from...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 94

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Kentucky Power's Bold Plan to Boost Local Economy

Updated Category News Views 199

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 74

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 133

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 168

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 75

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 154

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading

Top 5 Most Recently Viewed Articles

Chris Larsen's Strategic XRP Moves: Implications for Investors

Updated Category News Views 333

Overview of Chris Larsen's Recent XRP Transactions Chris Larsen, the influential co-founder and executive chairman of Ripple, has been actively transferring substantial amounts of XRP. Recently, he moved approximately $26 million worth of XRP to Coinbase, one of the most prominent cryptocurrency exchanges. This transfer is part of a larger pattern, contributing to an...

Continue Reading
Mastercard's Options Activity Insights: Market Trends Explored

Updated Category News Views 143

Understanding Mastercard's Recent Options Activity Mastercard is currently in the spotlight as investors engage in noteworthy bearish actions. This indicates a prevailing sentiment among wealthy clients regarding their perspective on the financial giant. Investor Insights on Mastercard Our analysis indicates that certain trades of interest have emerged in the options...

Continue Reading
Discover How CryptoGO Revolutionizes Memecoin Trading

Updated Category News Views 222

Transforming Memecoin Trading for Beginners CryptoGO is a innovative Telegram mini-app crafted specifically to ease the entry of newcomers into the world of memecoin trading. By harnessing the power of the Solana blockchain, CryptoGO revolutionizes how users engage with meme tokens, making the process both accessible and enjoyable. With support for fiat currency, users...

Continue Reading
Pyxis Oncology Updates on Financial Status and Future Plans

Updated Category News Views 325

Latest Developments at Pyxis Oncology Pyxis Oncology, Inc. has recently made headlines with its remarkable progress in the field of oncology. The development and ongoing trials of their innovative therapy, micvotabart pelidotin (MICVO), have shown encouraging preclinical results, highlighting its unique three-pronged mechanism of action. This mechanism enhances anti-tumor...

Continue Reading
Florida’s Cannabis Legalization Gains Momentum with Herald Support

Updated Category News Views 93

Support for Cannabis Legalization Gains Traction The Miami Herald, a notable publication in Florida with a rich history dating back to 1903, has come out strongly in favor of the state's cannabis legalization initiative known as Amendment 3. The proposal will be presented to voters in the upcoming election, marking a significant shift in public policy towards cannabis....

Continue Reading